$9.00
-0.68-7.02%
Pre-Market: 9:24 AM EDT
Comments
Loading...
Mineralys Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:MLYS | Benzinga
Mineralys Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-1.140
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Mineralys Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Mineralys Therapeutics (MLYS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $-0.98 | $-1.08 | 9.26 % |
| Q3 | 2024-11-11 | $-1.13 | $-0.83 | -36.1 % |
| Q2 | 2024-08-13 | $-0.83 | $-0.70 | -18.6 % |
| Q1 | 2024-05-09 | $-0.70 | $-0.67 | -4.48 % |
Mineralys Therapeutics (MLYS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?
Mineralys Therapeutics (MLYS) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 12, 2025 for Q4.
What were the latest earnings per share (EPS) for Mineralys Therapeutics (NASDAQ:MLYS)?
The Actual EPS was $-0.98, which beat the estimate of $-1.08.
What were Mineralys Therapeutics’s (NASDAQ:MLYS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.